These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3374448)

  • 1. [Antimeasles vaccination. Experience of a campaign with a population of 6410 susceptible subjects].
    Verrotti A; Chiarelli F; Di Santo S; Santoro R; Grandolfo ME; Morgese G
    Minerva Pediatr; 1988 Jan; 40(1):15-22. PubMed ID: 3374448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience of an antimeasles vaccination campaign].
    Marinello R; Pallaro M; Trevisan G
    Ann Sclavo; 1983; 24(3):315-7. PubMed ID: 6615041
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
    Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
    Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications of measles and antimeasles vaccination].
    Reinert P; Lemerle S; Kohout G; Bernaudin F
    Ann Pediatr (Paris); 1984 Jun; 31(6):477-80. PubMed ID: 6147112
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apropos of measles vaccination. Results of the first trials of antimeasles vaccination in France with hyperattenuated living virus vaccine].
    Mande R; Jammet ML; Celers J; Boué A
    Ann Pediatr (Paris); 1967 Jan; 14(1):66-73. PubMed ID: 5597350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience of a vaccination campaign using the Edmoston Zagreb strain (EZ 19) coinciding with reports about numerous cases of measles in the USL 23 region of Arezzo].
    Rossi PL; Poggini G; Bagianti C; Giglio E; Piergiovanni MG; Maruccia T; Pisano G
    Clin Ter; 1993 Apr; 142(4):335-40. PubMed ID: 8330476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of Guillain-Barré syndrome during measles elimination campaign in Izmir.
    Koturoglu G; Kurugol Z; Tekgul H; Ozcan T; Dizdarer C
    Minerva Pediatr; 2008 Dec; 60(6):1455-7. PubMed ID: 18971907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on measles 2010: Increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010: increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010.
    Cova M; Cucchi A; Turlà G; Codecà B; Buriani O; Gabutti G
    Euro Surveill; 2010 Dec; 15(50):. PubMed ID: 21172173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with vaccination against measles in Czech regions].
    Adam E; Domoráková E; Kratochvílová M; Burian V; Janotová J; Drevo M; Verhun V; Doubková S; Hartl J
    Cesk Pediatr; 1970 Sep; 25(9):438-40. PubMed ID: 5455607
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
    Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
    Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiment of vaccination against measles using attenuated virus (Schwarz strain) (author's transl)].
    Trivello R; Renzulli G; Romano M; Milone G; Moschen ME
    Ann Sclavo; 1978; 20(2):113-20. PubMed ID: 742926
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
    Stehr K; Enders G; Suschke HJ; Spiess H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
    Gigli L; Graziano M; Manetta G; Palombino R
    Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences.
    Majdzadeh R; Moradi A; Zeraati H; Sepanlou SG; Zamani G; Zonobi V
    East Mediterr Health J; 2008; 14(4):810-7. PubMed ID: 19166164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development and evolution of an antimeasles vaccine].
    Weibel RE
    Bol Oficina Sanit Panam; 1974 Aug; 77(2):135-40. PubMed ID: 4277803
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles epidemic attributed to inadequate vaccination coverage--Campania, Italy, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(43):1044-7. PubMed ID: 14586297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.